# FDA Inspection 1170450 - Brisar Industries, Inc. - May 10, 2022

Source: https://www.keypedia.com/records/fda_inspections/brisar-industries-inc/c447f121-beb3-42f1-9099-ee375625bf68
Source feed: FDA_Inspections

> FDA Inspection 1170450 for Brisar Industries, Inc. on May 10, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1170450
- Company Name: Brisar Industries, Inc.
- Inspection Date: 2022-05-10
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1083571 - 2018-12-21](https://www.keypedia.com/records/fda_inspections/brisar-industries-inc/79efa069-f3e7-4215-aa64-3a701dac3725)
- [FDA Inspection 1083571 - 2018-12-21](https://www.keypedia.com/records/fda_inspections/brisar-industries-inc/55605016-8aa0-486d-9e11-8f8d4825d606)
- [FDA Inspection 1012399 - 2017-04-03](https://www.keypedia.com/records/fda_inspections/brisar-industries-inc/ab08a817-9d8c-4c71-a6d7-5979256487ea)
- [FDA Inspection 903724 - 2014-11-20](https://www.keypedia.com/records/fda_inspections/brisar-industries-inc/6440da72-f008-42d5-b710-446ebe43459a)
- [FDA Inspection 903724 - 2014-11-20](https://www.keypedia.com/records/fda_inspections/brisar-industries-inc/0d3a9d1f-7c83-42f5-8f0d-12225ca41917)

Company: https://www.keypedia.com/companies/brisar-industries-inc/38da771c-5f7f-43c8-ae99-003597c5313d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c